AzTrials
AzTrials

Hip ArthroplastyNCT07851597

Randomized Study of Surgical Approach of Total Hip Arthroplasty (THA).

A study testing Total hip arthroplasty in people with Hip Arthroplasty, run by Uppsala University at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study intends to analyze the healing process of the hip muscle system and to evaluate the functional recovery score after performing a cemented primary THA for osteoarthritis (OA). Read more about this study

Who is it for?
Ages 60 to 80 years
Conditions the study is for
Hip Arthroplasty
What is being tested?
Total hip arthroplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSweden
Study dates
1 Mar 2021to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • hip osteoarthritis as indication for THA surgery
  • use of cemented prosthetic Components

Who cannot join

  • symptomatic osteoarthritis on the contralateral hip
  • neuromuscular disorder
  • dementia
  • BMI>40
  • previous surgery on any hip

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dimitrios Sotiriou, Medical doctor contact

+46762810301

dimitrios.sotiriou@regiongavleborg.se

Sweden1 site, 1 recruiting
  • Gävle hospital orthopaedic clinic

    Gävle

    Dimitrios Sotiriou, +46 26 158591, dimitrios.sotiriou@regiongavleborg.se

    Dimitrios Sotiriou

    Recruiting

Other trials in Sweden

About this study

Official title: Randomized Study of Surgical Approach of THA. CT/RSA, Radiography, HHS and Muscle Strength.

This study intends to analyze the healing process of the hip muscle system and to evaluate the functional recovery score after performing a cemented primary THA for osteoarthritis (OA).

Read the detailed description

This is a prospective , randomized study including 2 groups of 20 patients each. One group will be operated using a direct lateral approach and the other group will be operated using a posterolateral approach. After THA surgery, participants will be followed with plain radiography, Computed Tomography Micromotion Analysis (CTMA), clinical score and evaluation with inquiry letters. By use of CTMA, the study will analyze whether the re-attached muscle to bone is stable or not under the post-operative time period. In order to identify distinct points of measurement on skeleton, the CTMA protocol will be used to create a radiostereometric image of the bone. Muscle attachments will be marked by metal sutures visible on CT, making it feasible to measure eventual migration. The study will investigate the relationship between potential failure of muscle healing and postoperative muscle strength, pain, limping, and functional outcomes.

Being tested
Total hip arthroplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Total hip arthroplastyProcedure or surgery

    Marking of surgically detached tendons with metall markers. Radiostereometric analysis of the migration of the metall markers in different time points after surgery to evaluate healing or no healing of the tendons.

Study groups in NCT07851597
Study groupRoleWhat they receive
Direct lateral incisionActive comparatorNot described
Receives: Procedure: Total hip arthroplasty
Posterolateral incisionActive comparatorNot described
Receives: Procedure: Total hip arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hip abduction and external rotation strength in THA using direct lateral approach

    Hip abduction and external rotation muscle strength following THA using a direct lateral approach will be assessed using a handheld dynamometer. Strength of the operated hip will be compared with the contralateral hip and expressed as a strength ratio. In participants undergoing THA through the direct lateral approach, strength outcomes will be compared according to postoperative gluteus medius tendon healing status (healed vs non-healed), as assessed by CTMA. Tendon retraction on CTMA will be used to classify tendon healing status.

    Measured: Muscle strength preoperatively, at 3 months and 1 year after surgery.

  2. Hip abduction and external rotation strength in THA using posterolateral approach

    Hip abduction and external rotation muscle strength following THA using a posterolateral approach will be assessed using a handheld dynamometer. Strength of the operated hip will be compared with the contralateral hip and expressed as a strength ratio. In participants undergoing THA through the posterolateral approach, strength outcomes will be compared according to postoperative piriformis healing status (healed vs non-healed), as assessed by CTMA. Tendon retraction on CTMA will be used to classify tendon healing status.

    Measured: Muscle strength preoperatively, at 3 months and 1 year after surgery.

  3. Patient experiences based on interviews.

    A qualitative content analysis will be performed to explore patients' experiences of the undergoing surgical procedure and the rehabilitation period, including thoughts, concerns, emotions, and expectations related to recovery and the social environment.

    Measured: Interview 1 year after surgery.

Secondary outcomes (4)
  1. Hip abduction and external rotation strength in THA using direct lateral or posterolateral approach

    Hip abduction and external rotation muscle strength following THA using a direct lateral or a posterolateral approach will be assessed using a handheld dynamometer. Strength of the operated hip will be compared with the contralateral hip and expressed as a strength ratio. Strength outcomes will be compared between the two groups (direct lateral and posterolateral).

    Measured: Muscle strength preoperatively, at 3 months and 1 year after surgery.

  2. Clinical score evaluation using Harris Hip Score (HHS) inquiry.

    Comparison of HHS (0-100 rating scale, where higher scores indicate less disability and better hip health) between the two surgical approach groups (direct lateral and posterolateral approach) and between subgroups defined by tendon healing status (healed vs non-healed).

    Measured: HHS preoperatively, at 6 weeks and 1 year after surgery.

  3. Presence of Trendelenburg gait on clinical examination

    The presence or absence of Trendelenburg gait will be assessed by clinical examination after total hip arthroplasty. The frequency of Trendelenburg gait will be compared between the two surgical approach groups (direct lateral approach and posterior approach). Trendelenburg gait will also be compared between subgroups defined by postoperative tendon healing status (healed vs non-healed), as assessed by computed tomography motion analysis (CTMA).

    Measured: Preoperatively, at 6 weeks and 1 year after surgery.

  4. Comparison of patient health satisfaction as defined with the inquiry SF-36.

    Comparison of SF-36 outcomes between the two surgical approach groups (direct lateral and posterior approach) and between subgroups defined by tendon healing status (healed vs non-healed).

    Measured: SF-36 preoperatively, at 3 months and 1 year after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2026
  2. Study start1 Mar 2021
  3. Primary completionDec 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07851597
Sponsor's protocol ID
2019-06188
Other IDs
2019
Status last verified
Sep 2026
First submitted
18 Sep 2026
Last updated
1 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because of concerns regarding participant privacy and confidentiality. Only aggregated study results will be reported.

Questions about this trial

What is this clinical trial studying?

A study testing Total hip arthroplasty in people with Hip Arthroplasty, run by Uppsala University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dimitrios Sotiriou, Medical doctor (+46762810301, dimitrios.sotiriou@regiongavleborg.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hip abduction and external rotation strength in THA using direct lateral approach (time frame: Muscle strength preoperatively, at 3 months and 1 year after surgery.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in